Roche CE marks and launches cobas c 311

Roche Diagnostics has CE marked its cobas c 311 analyser for sale in Europe. It has launched the device in the EMEA region (Europe, the Middle East and South Africa), and Asian and Latin American markets. Basel, Switzerland-based Roche told Clinica that the instrument is cleared by the US FDA, but it is awaiting clearance of all the reagents. The analyser, which can carry out up to 300 tests per hour, is designed for small- and mid-volume labs. The cobas c 311 has a menu of over 100 assays and up to 45 can be performed simultaneously.

Roche Diagnostics has CE marked its cobas c 311 analyser for sale in Europe. It has launched the device in the EMEA region (Europe, the Middle East and South Africa), and Asian and Latin American markets. Basel, Switzerland-based Roche told Clinica that the instrument is cleared by the US FDA, but it is awaiting clearance of all the reagents. The analyser, which can carry out up to 300 tests per hour, is designed for small- and mid-volume labs. The cobas c 311 has a menu of over 100 assays and up to 45 can be performed simultaneously.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight